HK1247553A1 - 用於局部應用、去除和滅活治療劑或化妝品肉毒桿菌有毒成分的試劑盒 - Google Patents

用於局部應用、去除和滅活治療劑或化妝品肉毒桿菌有毒成分的試劑盒

Info

Publication number
HK1247553A1
HK1247553A1 HK18106889.1A HK18106889A HK1247553A1 HK 1247553 A1 HK1247553 A1 HK 1247553A1 HK 18106889 A HK18106889 A HK 18106889A HK 1247553 A1 HK1247553 A1 HK 1247553A1
Authority
HK
Hong Kong
Prior art keywords
inactivation
kits
therapeutic
removal
topical application
Prior art date
Application number
HK18106889.1A
Other languages
English (en)
Inventor
Jacob Waugh
Curtis Ruegg
Original Assignee
Revance Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46457668&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1247553(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Revance Therapeutics Inc filed Critical Revance Therapeutics Inc
Publication of HK1247553A1 publication Critical patent/HK1247553A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893Botulinum neurotoxin (3.4.24.69)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81Preparation or application process involves irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
HK18106889.1A 2011-01-07 2018-05-25 用於局部應用、去除和滅活治療劑或化妝品肉毒桿菌有毒成分的試劑盒 HK1247553A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161430868P 2011-01-07 2011-01-07

Publications (1)

Publication Number Publication Date
HK1247553A1 true HK1247553A1 (zh) 2018-09-28

Family

ID=46457668

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18106889.1A HK1247553A1 (zh) 2011-01-07 2018-05-25 用於局部應用、去除和滅活治療劑或化妝品肉毒桿菌有毒成分的試劑盒

Country Status (17)

Country Link
US (3) US20120294844A1 (zh)
EP (2) EP2661276B1 (zh)
JP (4) JP6444032B2 (zh)
BR (1) BR112013017311A2 (zh)
CY (1) CY1119427T1 (zh)
DK (1) DK2661276T3 (zh)
ES (1) ES2641068T3 (zh)
HK (1) HK1247553A1 (zh)
HR (1) HRP20171483T1 (zh)
HU (1) HUE035057T2 (zh)
LT (1) LT2661276T (zh)
NO (1) NO2661276T3 (zh)
PL (1) PL2661276T3 (zh)
PT (1) PT2661276T (zh)
RS (1) RS56460B1 (zh)
SI (1) SI2661276T1 (zh)
WO (1) WO2012094163A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2599017C (en) 2005-03-03 2014-08-12 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
SG10202100698QA (en) 2008-12-31 2021-02-25 Revance Therapeutics Inc Injectable Botulinum Toxin Formulations
US9340587B2 (en) 2009-06-25 2016-05-17 Revance Therapeutics, Inc. Albumin-free botulinum toxin formulations
CN104602703A (zh) * 2012-03-22 2015-05-06 雷文斯治疗公司 使用局部化学性去神经支配剂处理皱纹的方法
AU2016343748A1 (en) * 2015-10-29 2018-05-17 Revance Therapeutics, Inc. Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect
JP2019526611A (ja) 2016-09-13 2019-09-19 アラーガン、インコーポレイテッドAllergan,Incorporated 非タンパク質クロストリジウム毒素組成物
US20200179498A1 (en) * 2017-05-18 2020-06-11 Revance Therapeutics, Inc. Methods of treatment for cervical dystonia
EP3675900A4 (en) 2017-08-28 2021-05-05 Revance Therapeutics, Inc. TRANSMUCOSAL BOTULINUM TOXIN COMPOSITIONS, KITS, AND METHODS FOR TREATMENT OF BLADDER DISORDER
US20210321696A1 (en) * 2020-04-20 2021-10-21 First Step Holdings, Llc Covid mask

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286016A (en) * 1979-04-12 1981-08-25 The Drackett Company Pouch bleach
US4797128A (en) 1984-12-10 1989-01-10 Quadrex Hps, Inc. Method of and apparatus for cleaning garments and soft goods contaminated with nuclear, chemical and/or biological contaminants
US5877278A (en) 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
US5624636A (en) * 1994-11-07 1997-04-29 Univ. Of Texas Board Of Regents Hypochlorite based disinfectant for dental impressions
US6444209B1 (en) 1996-10-28 2002-09-03 Wisconsin Alumni Research Foundation Hybrid botulinal neurotoxins
US6566574B1 (en) 1998-06-30 2003-05-20 Sandia Corporation Formulations for neutralization of chemical and biological toxants
US6417423B1 (en) * 1998-09-15 2002-07-09 Nanoscale Materials, Inc. Reactive nanoparticles as destructive adsorbents for biological and chemical contamination
GB2386246B (en) 2001-11-01 2005-06-29 Marconi Applied Techn Ltd Electron beam tube apparatus
US6706092B2 (en) * 2002-04-17 2004-03-16 Alliedsignal Inc. Chemical/Biological decontamination filter
US7582595B1 (en) * 2002-11-06 2009-09-01 Taylor Lawnie H Hypochlorous acid/alkali metal hydoxide-containing products, methods and equipment for removing stains from fabrics
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
US7776292B2 (en) * 2004-01-16 2010-08-17 Cdic, Inc. Method and apparatus for bioweapon decontamination
SG150568A1 (en) * 2004-03-03 2009-03-30 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
WO2005114186A1 (ja) * 2004-05-20 2005-12-01 Wako Pure Chemical Industries, Ltd. ヒアルロン酸バインディングプロテインを用いたヒアルロン酸の測定方法
US20080220021A1 (en) 2005-02-14 2008-09-11 Pankaj Modi Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis
CA2599017C (en) * 2005-03-03 2014-08-12 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US20070154493A1 (en) * 2005-12-30 2007-07-05 Judy Hattendorf Method of treating skin needing botulinum toxin type a treatment
WO2007112286A2 (en) * 2006-03-24 2007-10-04 Auxilium Pharmaceuticals, Inc. Stabilized compositions containing alkaline labile drugs
JP2009534309A (ja) * 2006-03-31 2009-09-24 マサチューセッツ インスティテュート オブ テクノロジー 治療剤の標的化送達のためのシステム
DE102006019447A1 (de) * 2006-04-24 2007-10-25 Dressler, Dirk, Dr. Markierung von Botulinum Toxin
EP2117584B1 (en) * 2007-02-15 2013-10-09 Allergan, Inc. Use of botulinum toxin and enzymes for treating bladder disorders
CA2678580C (en) * 2007-03-06 2012-07-17 Steris Inc. Transportable decontamination unit and decontamination process
JP2009001423A (ja) * 2007-05-21 2009-01-08 Life:Kk 感染性廃棄物用回収袋又は容器および感染性廃棄物処理方法
WO2009042165A2 (en) * 2007-09-25 2009-04-02 Thomas Jefferson University Mutant botulinum neurotoxin serotype a polypeptide and uses thereof
US20090148342A1 (en) * 2007-10-29 2009-06-11 Bromberg Steven E Hypochlorite Technology
US20090250626A1 (en) * 2008-04-04 2009-10-08 Hexatech, Inc. Liquid sanitization device
SG10202100698QA (en) * 2008-12-31 2021-02-25 Revance Therapeutics Inc Injectable Botulinum Toxin Formulations
US9340587B2 (en) 2009-06-25 2016-05-17 Revance Therapeutics, Inc. Albumin-free botulinum toxin formulations

Also Published As

Publication number Publication date
EP3248614A1 (en) 2017-11-29
HRP20171483T1 (hr) 2017-12-01
SI2661276T1 (sl) 2017-12-29
EP2661276A4 (en) 2014-09-03
JP2018188447A (ja) 2018-11-29
EP2661276A1 (en) 2013-11-13
US20140154237A1 (en) 2014-06-05
RS56460B1 (sr) 2018-01-31
JP6444032B2 (ja) 2018-12-26
US20120294844A1 (en) 2012-11-22
BR112013017311A2 (pt) 2016-10-04
US20210189326A1 (en) 2021-06-24
PT2661276T (pt) 2017-10-06
JP2017025083A (ja) 2017-02-02
PL2661276T3 (pl) 2018-03-30
JP2020172519A (ja) 2020-10-22
ES2641068T3 (es) 2017-11-07
HUE035057T2 (en) 2018-05-02
EP2661276B1 (en) 2017-08-02
DK2661276T3 (en) 2017-10-02
LT2661276T (lt) 2017-12-11
CY1119427T1 (el) 2018-03-07
NO2661276T3 (zh) 2017-12-30
WO2012094163A1 (en) 2012-07-12
JP2014502969A (ja) 2014-02-06
JP6605420B2 (ja) 2019-11-13

Similar Documents

Publication Publication Date Title
HK1247553A1 (zh) 用於局部應用、去除和滅活治療劑或化妝品肉毒桿菌有毒成分的試劑盒
HK1245130A1 (zh) 酶組合物及其用於創傷愈合的用途
HRP20190318T1 (hr) Farmaceutski ili kozmetički pripravak za liječenje alopecije
EP2877159B8 (en) Efflux inhibitor compositions and methods of treatment using the same
HK1204930A1 (zh) 合歡提取物與對應局部合成物的新型化妝品應用
HK1205696A1 (zh) 用於微生物感染的局部治療的組合物
IL227538A0 (en) Topical minocycline compounds and methods of using them
EP2830654B8 (en) Methods and compositions for treating inflammation
EP2702982A4 (en) TOPICALLY APPLIED COMPOSITION FOR PREVENTING HAIR LOSS AND STIMULATING HAIR GROWTH
EP2766009A4 (en) METHOD AND COMPOSITIONS FOR SKIN TREATMENT
EP2729156A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF FAT PATRICK SKIN TYPES IV, V AND VI
PL2694021T3 (pl) Kompozycja gojąca do stosowania zewnętrznego
EP2866830A4 (en) ANTI-CXCL9, ANTI-CXCL10, ANTI-CXCL11, ANTI-CXCL13, ANTI-CXCR3 AND ANTI-CXCR5 AGENTS FOR THE INHIBITION OF INFLAMMATION
EP2786738A4 (en) HAIR TREATMENT COMPOSITION
KR20180085062A (ko) 피부 상태를 치료하기 위한 조성물 및 방법
HK1200364A1 (zh) 外用成膜組合物 其用於處理或預防咬指甲癖的用途
WO2013003465A9 (en) Methods and compositions for treating skin
EP2695604A4 (en) SPIRULIN-BASED COSMETIC COMPOSITION AND COSMETIC TREATMENT PROCESS
EP2772248A4 (en) PHARMACEUTICAL COMPOSITION AND KIT FOR THE TREATMENT OF BACTERIAL INFECTIONS
AU2012902296A0 (en) Compositions for Therapy and Methods of Treatment
AU2011902707A0 (en) Methods and compositions useful for treating fitzpatrick type IV, V or VI skin
AU2011902129A0 (en) Compositions for Therapy and Methods of Treatment
AU2011903595A0 (en) Anti-thrombotic agent and methods of treatment
AU2011900328A0 (en) Composition and method for the treatment of headache
AU2012902982A0 (en) Compositions and methods for the treatment of tuberculosis